Yvonne Barr
Yvonne Barr is a virologist known for her contributions to the discovery of the Epstein-Barr virus (EBV), a significant achievement in the field of virology and oncology. Her work alongside Michael Anthony Epstein and Bert Achong in the 1960s led to the identification of the virus in Burkitt's lymphoma cells, marking a pivotal moment in the understanding of virus-related cancers.
Early Life and Education[edit | edit source]
Yvonne Barr's early life and educational background remain less documented in public records. However, her academic journey led her to the field of virology, where she made significant contributions.
Career and Research[edit | edit source]
Yvonne Barr's career is most notably associated with her work at the University of London, where she was part of a research team focused on studying viral oncology. In 1964, Barr, along with Epstein and Achong, discovered the Epstein-Barr virus. This discovery was groundbreaking as EBV was the first virus to be directly implicated in the causation of cancer, specifically Burkitt's lymphoma, a type of non-Hodgkin lymphoma.
The identification of EBV opened new avenues for research in virology and oncology, leading to further understanding of the virus's role in other diseases, such as Infectious mononucleosis, and its association with other types of cancers like nasopharyngeal carcinoma and some forms of gastric cancer.
Legacy and Impact[edit | edit source]
Yvonne Barr's work has had a lasting impact on the medical and scientific community. The discovery of the Epstein-Barr virus not only advanced the field of virology but also contributed significantly to the understanding of how viruses can cause cancer. This has paved the way for research into vaccines and treatments for EBV-related diseases.
Her contributions, along with those of her colleagues, have been recognized as a milestone in the study of virus-induced cancers, influencing generations of researchers and clinicians in the pursuit of understanding and combating viral oncology.
See Also[edit | edit source]
 | This oncology article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
